Phase I Clinical Pharmacology Study of F14512, a New Polyamine-Vectorized Anticancer Drug, in Naturally Occurring Canine Lymphoma (Q38853518)
Jump to navigation
Jump to search
scientific article published on 13 July 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I Clinical Pharmacology Study of F14512, a New Polyamine-Vectorized Anticancer Drug, in Naturally Occurring Canine Lymphoma |
scientific article published on 13 July 2015 |
Statements
1 reference
Phase I Clinical Pharmacology Study of F14512, a New Polyamine-Vectorized Anticancer Drug, in Naturally Occurring Canine Lymphoma (English)
1 reference
Dominique Tierny
1 reference
François Serres
1 reference
Zacharie Segaoula
1 reference
Ingrid Bemelmans
1 reference
Emmanuel Bouchaert
1 reference
Aurélie Pétain
1 reference
Viviane Brel
1 reference
Stéphane Couffin
1 reference
Thierry Marchal
1 reference
Nicolas Guilbaud
1 reference
Bruno Gomes
1 reference
13 July 2015
1 reference
1 reference
21
1 reference
23
1 reference
5314-5323
1 reference
Identifiers
1 reference
1 reference